| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Investing > New Mine Flood Further Tightens Uranium Supply |
|
Top Articles - New Mine Flood Further Tightens Uranium Supply
After Cameco Corp’s Cigar Lake flood at the company’s northern Saskatchewan uranium mining project rattled analysts and ut According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ilities who previously expected sufficient uranium would be available to meet the needs of nuclear utilities, along came a ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in other mine flooding – this one in Australia. The March 7th announcement by Energy Resources of Australia was different. Wh lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ile Cigar Lake effectively removed uranium mining supply in 2008, ERA’s ‘force majeure’ announcement withdrew supply antic here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe pated for this year. Even before the force majeure, TradeTech’s Nuclear Market Review was inclined to increase the consul d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ting service’s weekly spot uranium price indicator. Flooding at ERA’s Ranger mining operations confirmed the already very ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ight uranium supply would get much tighter. And it will cost delinquent utilities who did not stockpile sufficient uranium easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi to meet their reactor requirements to pay more for new uranium supply they may have need of. Presently at US$90/pound, i nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically appears a sure thing that spot uranium would rise past the century mark and perhaps gallop higher. TradeTech announced th and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ at ERA’s force majeure ‘stunned’ nuclear utilities. Active demand for uranium is currently running more than two to one. M ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi re utilities want to buy uranium than what is presently offered. Utilities, which were locked-in ERA contracts, were payin ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a the Australian subsidiary of Rio Tinto about $22/pound. Now, utilities will be forced to pay about five times the price f dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod or the same uranium. ERA supplies utilities in North America, Europe and Asia. The company provides about 11 percent of t cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e world’s uranium mining supply. It is the world’s third largest producer. The impact of this flooding has not yet been ev tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen aluated. Preliminary estimates for the first quarter 2007 could mean a loss of nearly one million pounds. Because of the c t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel mpany’s force majeure announcement and the company’s official statement that “production will be impacted in the second ha ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust lf of 2007,” TradeTech’s Gene Clark estimated the loss of newly mined uranium could run much higher. As we discovered aft y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products r the Cigar Lake mine flood, imminent uranium producers, and others whose projects were moving forward to production, grea . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de tly benefited by the disaster in terms of share price appreciation. The recent ERA flood and the suspense about Cameco Cor elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ’s announcement of remediation efforts, due this month, should keep uranium stocks buoyant for at least the next few weeks tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:A Creative Approach to Strategic Sourcing and Supplier Engagement A Great Place to Start Your Online Career - Affiliate Marketing
|